Redeye is overall positive about CLS entering a strategic partnership with its German fibre-optics manufacturing partner advanced fiber tools GmbH (AFT), aimed at identifying and developing new medical laser products for therapeutic areas beyond neurosurgery and urology. However, as the agreement is a non-exclusive framework without financial commitments or guaranteed volumes, we see it as an option on the case rather than something that adds tangible value today. Given the early stage, we make no changes to our estimates.
LÄS MER